JUNIPERUS VIRGINIANA POLLEN: 62 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
62
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
62
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20160112 · Latest Report: 20250304
What Are the Most Common JUNIPERUS VIRGINIANA POLLEN Side Effects?
#1 Most Reported
Anaphylactic reaction
11 reports (17.7%)
#2 Most Reported
Injection site reaction
10 reports (16.1%)
#3 Most Reported
Pruritus
9 reports (14.5%)
All JUNIPERUS VIRGINIANA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 11 | 17.7% | 0 | 1 |
| Injection site reaction | 10 | 16.1% | 0 | 0 |
| Dizziness | 9 | 14.5% | 0 | 0 |
| Pruritus | 9 | 14.5% | 0 | 0 |
| Cough | 8 | 12.9% | 0 | 0 |
| Rhinorrhoea | 8 | 12.9% | 0 | 0 |
| Throat irritation | 8 | 12.9% | 0 | 0 |
| Wheezing | 7 | 11.3% | 0 | 0 |
| Dyspnoea | 6 | 9.7% | 0 | 0 |
| Local reaction | 6 | 9.7% | 0 | 0 |
| Chest discomfort | 5 | 8.1% | 0 | 0 |
| Flushing | 5 | 8.1% | 0 | 0 |
| Hypersensitivity | 5 | 8.1% | 0 | 0 |
| Urticaria | 5 | 8.1% | 0 | 0 |
Who Reports JUNIPERUS VIRGINIANA POLLEN Side Effects? Age & Gender Data
Gender: 63.9% female, 36.1% male. Average age: 38.3 years. Most reports from: US. View detailed demographics →
Is JUNIPERUS VIRGINIANA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 9 | 0 | 0 |
| 2017 | 4 | 0 | 0 |
| 2018 | 2 | 0 | 0 |
| 2019 | 2 | 0 | 0 |
| 2020 | 8 | 0 | 0 |
| 2021 | 8 | 0 | 0 |
| 2022 | 12 | 0 | 0 |
| 2023 | 2 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is JUNIPERUS VIRGINIANA POLLEN Used For?
| Indication | Reports |
|---|---|
| Seasonal allergy | 6 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for JUNIPERUS VIRGINIANA POLLEN
Official prescribing information from the FDA-approved drug label.